China's Sinovac to double annual Covid-19 vaccine capacity to one billion doses

BEIJING (Reuters): A unit of Sinovac Biotech could double annual production capacity of its CoronaVac Covid-19 vaccine to 1 billion doses by February, the group's chairman said on Wednesday (Jan 13).

More than 7 million doses of CoronaVac vaccine, one of the three China has included in its emergency vaccination programme, have so far been supplied to regions including the city of Beijing and Guangdong province, Sinovac Biotech Chairman Yin Weidong told a news conference.